| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| alitretinoin | cytochrome p450 26c1 | small molecule | NA | drugbank | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
NA | approved,investigational | unknown |
| alitretinoin | insulin-like growth factor-binding protein 3 | small molecule | NA | drugbank | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
NA | approved,investigational | unknown |
| alitretinoin | pregnancy-specific beta-1-glycoprotein 5 | small molecule | NA | drugbank | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
NA | approved,investigational | unknown |
| alitretinoin | retinoic acid receptor alpha | small molecule | NA | drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
2.74 | approved,investigational | agonist |
| alitretinoin | retinoic acid receptor beta | small molecule | Successful target | TTD , drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
4.71 | approved,investigational | agonist |
| alitretinoin | retinoic acid receptor gamma | small molecule | Successful target | TTD , drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
3.74 | approved,investigational | agonist |
| alitretinoin | retinoic acid receptor rxr-alpha | small molecule | Successful target | TTD , drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
1.45 | approved,investigational | agonist |
| alitretinoin | retinoic acid receptor rxr-beta | small molecule | Successful target | TTD , drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
7.86 | approved,investigational | agonist |
| alitretinoin | retinoic acid receptor rxr-gamma | small molecule | Successful target | TTD , drugbank , DGIDB | AIDS with Kaposi's sarcoma[MeSHID:C554498] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Kaposi Sarcoma[MeSHID:D012514] |
8.84 | approved,investigational | agonist |
| click here to return to the previous page | ||||||||